Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 30, 2026

Autoliv (ALV) Q4 2025 Earnings Call Transcript

View original at finance.yahoo.com
Autoliv (ALV) Q4 2025 Earnings Call Transcript Image source: The Motley Fool. Date Friday, January 30, 2026 at 8 a.m. ET Call participants President and Chief Executive Officer — Mikael Bratt Chief Financial Officer — Fredrik Westin Full Conference Call Transcript Mikael Bratt: Thank you, Anders…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Working capital improvement target of $800M achieved approximately $740M over 5 years

    80% confidence
  • India market expected to grow 8% in 2026 due to tax reductions on smaller and lower-priced vehicles

    80% confidence
  • 2026 adjusted operating margin expected to be 10.5-11%

    80% confidence
  • Q1 2026 global LVP expected to decline 4% year-over-year and 14% sequentially

    80% confidence
  • CPV range is $150-$400+ with higher values from front center airbags

    80% confidence
  • China LVP expected to decline more than 10% in Q1 2026 due to reduced scrapping and NEV incentives and high inventory

    80% confidence
  • North America market expected to decline 2% in 2026 due to USMCA uncertainty and inflation

    80% confidence
  • Achieved ~100% tariff recovery in Q4 2025

    80% confidence
  • Record number of launches expected in 2026, driven by Chinese OEMs

    80% confidence
  • Chinese OEMs now represent 44% of China sales versus 22% three years ago

    80% confidence
  • More than 30% of 2025 global order intake came from Chinese OEMs

    80% confidence
  • Global market share is approximately 44% versus ~39% post-Veoneer 2018 spinoff

    80% confidence
  • 2026 organic sales expected to be flat with China, India, and South America growth offset by North America and Europe declines

    80% confidence
  • Achieved $100M of $130M structural cost savings target, with $20M expected in 2026 and $10M in 2027

    80% confidence
  • No indication that Hyundai airbag recall involves Autoliv products

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com